ViiV Fall Webinars
Please join this topic specific research discovery session covering ViiV sponsored clinical data presented at the fall webinars in 2020
GEMINI 144 Week: Efficacy and Safety - Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
Please join with ViiV Senior Medical Experts in the presentation of the GEMINI 144 week data evaluating the long term efficacy and safety comparing DTG/3TC to a 3 drug regimenGlasgow 2020, October 2020
TANGO 96 Week: Efficacy and Safety – Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
Please join with ViiV senior Medical Experts in the presentation of the TANGO 96 week data comparing DTG/3TC to a TAF-based regimen in maintaining virologic suppression in a switch populationHIV Glasgow 2020, October 2020
GEMINI 48 Week: Adherence Analysis - Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
Please join with ViiV Senior Medical Experts in the presentation of the impact of treatment adherence on the efficacy of DTG/3TC vs DTG+TDF/FTC from the GEMINI 1 and 2 studiesGlasgow 2020, October 2020
STAT 24 Week: Feasibility, Efficacy and Safety - Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
Please join with ViiV Senior Medical Experts in evaluating the feasibility, efficacy, and safety using DTG/3TC as a first line regimen in a test and treat setting for newly diagnosed people living with HIV (PLWH)ACTHIV 2020, August 20, 2020
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch